Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leticia De Mattos-Arruda

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
ESMO Open|October 26, 2017
Liquid biopsy for HER2-positive breast cancer brain metastasis: the role of the cerebrospinal fluidLeticia De Mattos-Arruda
ESMO Open|August 21, 2020
<i>PIK3CA</i> mutation inhibition in hormone receptor-positive breast cancer: time has comeLeticia De Mattos-Arruda
Advances in Therapy|July 25, 2013
Use of pertuzumab for the treatment of HER2-positive metastatic breast cancerLeticia De Mattos-Arruda, Javier Cortes
Cancer Discovery|November 5, 2014
Escaping out of the brainJoan Seoane, Leticia De Mattos-Arruda
Molecular Oncology|January 19, 2016
Cell-free circulating tumour DNA as a liquid biopsy in breast cancerLeticia De Mattos-Arruda, Carlos Caldas
The Oncologist|April 24, 2012
Advances in first-line treatment for patients with HER-2+ metastatic breast cancerLeticia De Mattos-Arruda, Javier Cortes
The Oncologist|October 19, 2013
Pilot studies for personalized cancer medicine: focusing on the patient for treatment selectionLeticia De Mattos-Arruda, Jordi Rodon
Molecular Oncology|June 24, 2014
Brain metastasis: new opportunities to tackle therapeutic resistanceJoan Seoane, Leticia De Mattos-Arruda
Breast (Edinburgh, Scotland)|May 8, 2012
Breast cancer and HSP90 inhibitors: is there a role beyond the HER2-positive subtype?Leticia De Mattos-Arruda, Javier Cortes
Clinical Colorectal Cancer|July 7, 2011
Development of molecular biomarkers in individualized treatment of colorectal cancerLeticia De Mattos-Arruda, Rodrigo Dienstmann, Josep Tabernero
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
ESMO Open|October 26, 2017
Liquid biopsy for HER2-positive breast cancer brain metastasis: the role of the cerebrospinal fluidLeticia De Mattos-Arruda
ESMO Open|August 21, 2020
<i>PIK3CA</i> mutation inhibition in hormone receptor-positive breast cancer: time has comeLeticia De Mattos-Arruda
Advances in Therapy|July 25, 2013
Use of pertuzumab for the treatment of HER2-positive metastatic breast cancerLeticia De Mattos-Arruda, Javier Cortes
Cancer Discovery|November 5, 2014
Escaping out of the brainJoan Seoane, Leticia De Mattos-Arruda
Molecular Oncology|January 19, 2016
Cell-free circulating tumour DNA as a liquid biopsy in breast cancerLeticia De Mattos-Arruda, Carlos Caldas
The Oncologist|April 24, 2012
Advances in first-line treatment for patients with HER-2+ metastatic breast cancerLeticia De Mattos-Arruda, Javier Cortes
The Oncologist|October 19, 2013
Pilot studies for personalized cancer medicine: focusing on the patient for treatment selectionLeticia De Mattos-Arruda, Jordi Rodon
Molecular Oncology|June 24, 2014
Brain metastasis: new opportunities to tackle therapeutic resistanceJoan Seoane, Leticia De Mattos-Arruda
Breast (Edinburgh, Scotland)|May 8, 2012
Breast cancer and HSP90 inhibitors: is there a role beyond the HER2-positive subtype?Leticia De Mattos-Arruda, Javier Cortes
Clinical Colorectal Cancer|July 7, 2011
Development of molecular biomarkers in individualized treatment of colorectal cancerLeticia De Mattos-Arruda, Rodrigo Dienstmann, Josep Tabernero
Pageof 5